Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging

Clinical Radiology

Volumn 64, Issue 1, 2009, Pages 22-29

  Chou, C T ^a,b   Chen, R C ^a,c   Chen, W T ^c   Lii, J M ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Chang Hua Christian Hospital

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES;

EID: 57349153975     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2008.07.010     Document Type: Article

References (22)

1. Szklaruk J., Silverman P.M., and Charnsangavej C. Imaging in the diagnosis, staging, treatment and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol 180 (2003) 441-454
2. Noone T.C., Semmelka R.C., Chaney D.M., et al. Abdominal imaging studies; comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual. Magn Reson Imaging 22 (2004) 19-24
3. Tanimoto A., and Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 58 (2006) 200-216
4. Kanematsu M., Matsuo M., Yamada Y., et al. Perilesional hyperintense rim of malignant hepatic tumours on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging 18 (2003) 40-48
5. Koushima Y., Ebara M., Fukuda H., et al. Small hepatocellular carcinoma: assessment with T1-weighted spin-echo magnetic resonance imaging with and without fat suppression. Eur J Radiol 41 (2002) 34-41
6. Imai Y., Murakami T., Yoshida S., et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32 (2000) 205-212
7. Efremidis S.C., Hytiroglou P., and Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 17 (2007) 2969-2982
8. Landis J.R., and Koch G.G. The measurement of observer agreement for categrorical data. Biometrics 33 (1977) 159-174
9. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
10. Reimer P., Jahnke N., Fiebich M., et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217 (2000) 152-158
11. Poeckler-Schoeniger C., Koepke J., Gueckel F., et al. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imaging 17 (1999) 383-392
12. Ward J., Robinson P.J., Guthrie J.A., et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237 (2005) 170-180
13. Tanimoto A., Wakabayashi G., Shinmoto H., et al. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells. J Magn Reson Imaging 21 (2005) 230-236
14. Macarini L., Marini S., Murrone M., et al. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis. Radiol Med 108 (2004) 92-106
15. Lee J.M., Kim C.S., Youk J.H., et al. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Korean J Radiol 4 (2003) 9-18
16. Oswald P., Clement O., Chambon C., et al. Liver positive enhancement after injection of superparamagnetic nanoparticles: respective role of circulating and uptaken particles. Magn Reson Imaging 15 (1997) 1025-1031
17. Hamm B., Staks T., and Taupitz M. SHU 555A. A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging. Invest Radiol 29 Suppl. 2 (1994) S87-S89
18. Hamm B., Staks T., Taupitz M., et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 4 (1994) 659-668
19. Kim J.H., Kim M.J., Suh S.H., et al. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 15 (2002) 573-583
20. Van Beers B.E., Gallez B., and Pringot J. Contrast-enhanced MR imaging of the liver. Radiology 203 (1997) 297-306
21. Torzilli G., Minagawa M., Takayama T., et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30 (1999) 889-893
22. Kim Y.K., Kwak H.S., Kim C.S., et al. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 238 (2006) 531-541